Beta-blockers provide extra years for cancer patients

2015 Research

Beta-blockers are well known drugs, but not without side-effects sadly. However, in cancer treatment their benefits may well outweigh their negatives.

In a retrospective study, researchers from MD Anderson showed that women with ovarian cancer who were taking beta-blockers lived on average more than four years longer than those who were not. There are 21,000 cases of ovarian cancer in America each year and two thirds of those die from the disease.

This is not the first time beta-blockers have shown an anti-cancer effect. It has long been known that chronic inflammation promotes cancer spread and that stress hormones and adrenaline exacerbate this. Beta blockers can mitigate this.


2015 Research
CancerAcitve Logo
Subscribe (Free e-Newsletter)

Join Our

Join Our Newsletter Signup today for free and be the first to get notified on new updates.